Kilic Salih, Turkoglu Cuneyt
Department of Cardiology, Doctor Ersin Arslan Research and Training Horpital, Gaziantep, Turkey.
Department of Cardiology, Ege University Faculty of Medicine, Izmir, Turkey.
Cardiol Res. 2019 Feb;10(1):34-39. doi: 10.14740/cr817. Epub 2019 Feb 24.
We aimed to compare outcomes of patients received successful fibrinolytic treatment (FT) for ST-segment elevated myocardial infarction (STEMI) and performed coronary angiography (CAG) within 24 - 72 h or after 72 h.
Between March 2013 and November 2014, 76 STEMI patients received successful FT and performed CAG > 24 h were included in the study. Patients were divided into two groups according to the time-interval from FT admission to CAG performing (Group-1, 24 - 72 h (n = 29), Group-2, > 72 h (n = 47)). The primary end point was major adverse cardiac events (MACE) defined as cardiovascular death, non-fatal myocardial infarction, and heart failure.
The mean age of patients were 56 ± 11.4 years old (27.6% female). CAG was performed within mean 2.17 ± 0.38 days in the Group-1 and 2.9 ± 11.5 days in the Group 2 (P < 0.001). At short-term follow-up (6 months), MACE rate was higher in Group-2 (21.3%) than Group-1(13.8%), but it was not statistically significant (P = 0.661). The rate of MACE was 37.9% in Group-1 and 38.3% in Group-2 (P = 0.974) in the long-term follow-up (median: 57 months). Overall cardiac mortality rate was 7.9%, the re-infarction rate was 19.7% and heart failure was 17.1% in long-term follow-up, and there were no significant difference between groups.
Present study has shown that performance of CAG after 24 h of successful FT, within 24 - 74 h or > 72 h, did not shown any difference in term of MACE both in short and long-term follow-up.
我们旨在比较接受成功的纤维蛋白溶解治疗(FT)的ST段抬高型心肌梗死(STEMI)患者在24 - 72小时内或72小时后进行冠状动脉造影(CAG)的结果。
2013年3月至2014年11月期间,76例接受成功FT并在>24小时后进行CAG的STEMI患者纳入研究。根据从FT入院到进行CAG的时间间隔将患者分为两组(第1组,24 - 72小时(n = 29),第2组,>72小时(n = 47))。主要终点是定义为心血管死亡、非致命性心肌梗死和心力衰竭的主要不良心脏事件(MACE)。
患者的平均年龄为56±11.4岁(27.6%为女性)。第1组平均在2.17±0.38天内进行CAG,第2组为2.9±11.5天(P<0.001)。在短期随访(6个月)时,第2组的MACE发生率(21.3%)高于第1组(13.8%),但差异无统计学意义(P = 0.661)。在长期随访(中位数:57个月)中,第1组的MACE发生率为37.9%,第2组为38.3%(P = 0.974)。长期随访的总体心脏死亡率为7.9%,再梗死率为19.7%,心力衰竭为17.1%,两组之间无显著差异。
本研究表明,成功FT 24小时后在24 - 74小时内或>72小时进行CAG,在短期和长期随访的MACE方面均未显示出任何差异。